197 related articles for article (PubMed ID: 34245791)
1. A novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk).
Kayvanpour E; Sammani A; Sedaghat-Hamedani F; Lehmann DH; Broezel A; Koelemenoglu J; Chmielewski P; Curjol A; Socie P; Miersch T; Haas J; Gi WT; Richard P; Płoski R; Truszkowska G; Baas AF; Foss-Nieradko B; Michalak E; Stępień-Wojno M; Zakrzewska-Koperska J; Śpiewak M; Zieliński T; Villard E; Te Riele ASJM; Katus HA; Frey N; Bilińska ZT; Charron P; Asselbergs FW; Meder B
Int J Cardiol; 2021 Sep; 339():75-82. PubMed ID: 34245791
[TBL] [Abstract][Full Text] [Related]
2. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
3. Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction.
Merlo M; Gentile P; Artico J; Cannatà A; Paldino A; De Angelis G; Barbati G; Alonge M; Gigli M; Pinamonti B; Ramani F; Zecchin M; Pirozzi F; Stolfo D; Sinagra G
J Cardiovasc Med (Hagerstown); 2019 May; 20(5):343-350. PubMed ID: 30921270
[TBL] [Abstract][Full Text] [Related]
4. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
5. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
[TBL] [Abstract][Full Text] [Related]
6. Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy.
Setti M; Merlo M; Gigli M; Munaretto L; Paldino A; Stolfo D; Pio Loco C; Medo K; Gregorio C; De Luca A; Graw S; Castrichini M; Cannatà A; Ribichini FL; Dal Ferro M; Taylor M; Sinagra G; Mestroni L
Eur J Heart Fail; 2024 Mar; 26(3):581-589. PubMed ID: 38404225
[TBL] [Abstract][Full Text] [Related]
7. Left atrial booster pump function is an independent predictor of subsequent life-threatening ventricular arrhythmias in non-ischaemic cardiomyopathy.
Negishi K; Negishi T; Zardkoohi O; Ching EA; Basu N; Wilkoff BL; Popović ZB; Marwick TH
Eur Heart J Cardiovasc Imaging; 2016 Oct; 17(10):1153-60. PubMed ID: 26710819
[TBL] [Abstract][Full Text] [Related]
8. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
9. Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis.
Stolfo D; Albani S; Savarese G; Barbati G; Ramani F; Gigli M; Biondi F; Dal Ferro M; Zecchin M; Merlo M; Sinagra G
Int J Cardiol; 2020 May; 307():75-81. PubMed ID: 32067834
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention implantable cardioverter-defibrillator use in non-ischemic dilated cardiomyopathy based on arrhythmic risk stratification and left ventricular reverse remodeling prediction.
Muhammed A; Abdelazeem M; Elewa MG; Sharief M; Ammar A
Heart Fail Rev; 2023 Jan; 28(1):229-240. PubMed ID: 35587303
[TBL] [Abstract][Full Text] [Related]
11. Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more.
Makati KJ; Fish AE; England HH; Tighiouart H; Estes NA; Link MS
Heart Rhythm; 2006 Apr; 3(4):397-403. PubMed ID: 16567284
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias.
Spezzacatene A; Sinagra G; Merlo M; Barbati G; Graw SL; Brun F; Slavov D; Di Lenarda A; Salcedo EE; Towbin JA; Saffitz JE; Marcus FI; Zareba W; Taylor MR; Mestroni L;
J Am Heart Assoc; 2015 Oct; 4(10):e002149. PubMed ID: 26475296
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
[TBL] [Abstract][Full Text] [Related]
15. Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse.
Dognin N; Rimac G; Domain G; Cinq-Mars A; Massot M; Turgeon PY; Dubois-Sénéchal SM; Bourgault C; Morin J; Bernier M; Beaudoin J; Laflamme M; Charbonneau E; Strubé C; Voisine P; Philippon F; Belzile D; Sénéchal M
Pacing Clin Electrophysiol; 2023 Jul; 46(7):645-656. PubMed ID: 37247219
[TBL] [Abstract][Full Text] [Related]
16. Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.
Di Marco A; Anguera I; Schmitt M; Klem I; Neilan TG; White JA; Sramko M; Masci PG; Barison A; Mckenna P; Mordi I; Haugaa KH; Leyva F; Rodriguez Capitán J; Satoh H; Nabeta T; Dallaglio PD; Campbell NG; Sabaté X; Cequier Á
JACC Heart Fail; 2017 Jan; 5(1):28-38. PubMed ID: 28017348
[TBL] [Abstract][Full Text] [Related]
17. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.
Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Arrhythmic Risk Assessment Based on Ejection Fraction in Patients with Recent-Onset Nonischemic Dilated Cardiomyopathy.
De Angelis G; Merlo M; Barbati G; Bertolo S; De Luca A; Ramani F; Adamo L; Sinagra G
J Am Soc Echocardiogr; 2022 Aug; 35(8):801-809.e3. PubMed ID: 35367610
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy.
Stolfo D; Ceschia N; Zecchin M; De Luca A; Gobbo M; Barbati G; Gigli M; Masè M; Pinamonti B; Pivetta A; Merlo M; Sinagra G
Am J Cardiol; 2018 Jun; 121(12):1601-1609. PubMed ID: 29678335
[TBL] [Abstract][Full Text] [Related]
20. Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators.
Corden B; Jarman J; Whiffin N; Tayal U; Buchan R; Sehmi J; Harper A; Midwinter W; Lascelles K; Markides V; Mason M; Baksi J; Pantazis A; Pennell DJ; Barton PJ; Prasad SK; Wong T; Cook SA; Ware JS
JAMA Netw Open; 2019 Jun; 2(6):e196520. PubMed ID: 31251381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
